2026 Global: Cell Culture Media Bags Market -Competitive Review (2032) report
Description
The 2026 Global: Cell Culture Media Bags Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cell culture media bags market by geography and historical trend. The scope of the report extends to sizing of the cell culture media bags market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Thermo Fisher Scientific leads the cell culture media bags market with an extensive single-use portfolio that integrates media bags, connectors, and validated workflows under brands such as Gibco and Thermo Scientific, supporting applications from research through commercial biomanufacturing and benefiting from global manufacturing and distribution capabilities that ensure rapid supply to biopharma customers. Sartorius AG competes strongly through differentiated film chemistries and configurable bag designs optimized for gas permeability and sterility, leveraging its Bioprocess Solutions division and regional production sites to shorten lead times for large-volume (50–500 L and above) formats favored in clinical and pilot-scale production. Danaher (including Pall and Cytiva businesses) offers an expansive single-use platform that spans media preparation, sterile transfer, and filtration components, strengthened by strategic acquisitions that broaden its end-to-end bioprocessing reach and position it as a supplier for high-density, high-volume processes. Merck KGaA (MilliporeSigma in some regions) supplies media bags alongside a broad cell culture media and reagent portfolio under cGMP conditions, emphasizing batch-to-batch consistency, custom formulation services, and validated raw materials for cell and gene therapy workflows. Corning provides engineered single-use media bags and related disposables designed for integration with cell culture systems, emphasizing transparency, handling ergonomics, and compatibility with scaling processes from stem cell research to commercial production. Lonza Group supplies cell therapy–focused media bag solutions as part of its broader CDMO and contract development services, catering to the specialized needs of cell and gene therapy manufacturers and supporting large-scale clinical supply chains. Saint-Gobain Performance Plastics and Saint-Gobain subsidiaries produce advanced multilayer films and tubing used in media bag manufacture, focusing on polymer chemistries that improve oxygen/moisture barriers, reduce extractables, and extend shelf life for sensitive cultures. Parker Hannifin (SciLog) and Meissner Filtration Products offer complementary single-use fluid handling and sterile transfer systems plus reinforced bag designs and connector technologies that address rapid media transfer, aseptic sampling, and handling for high-volume operations. Fujifilm Irvine Scientific and Takara Bio provide application-focused media and bag combinations—pairing proprietary media formulations with compatible single-use containers and sampling ports to streamline validation and reduce compatibility risk for researchers and manufacturers moving to disposable workflows.
Across these ten companies, common competitive advantages include vertically integrated product lines, validated single-use systems, global manufacturing footprints, and materials science expertise that advances multilayer film technologies for improved gas exchange and reduced extractables—attributes critical as demand shifts toward larger bag formats and higher cell densities driven by monoclonal antibody production, vaccines, and cell and gene therapies. Strategic activity among leaders includes capacity expansions, targeted acquisitions to fill portfolio gaps (for example, filtration, connectors, or media), and product launches featuring integrated sampling, wider-bore ports, and reinforced handles to meet operational needs in GMP environments and decentralized modular biomanufacturing. Market reports indicate moderate consolidation with the top suppliers capturing a majority share of revenue, and projections show continuing growth driven by single-use adoption, rising biopharma production volumes, and increased R&D in regenerative medicine and cell therapies that demand sterile, scalable, and validated media bag solutions.
Innovation and regional manufacturing scale will likely determine near-term leadership as buyers prioritize supply security, regulatory support, and systems interoperability; manufacturers that combine advanced film chemistries, customizable configurations, and integrated service offerings (media formulation plus compatible bag systems) are best positioned to capture white-space opportunities in emerging markets and in high-volume formats above 500 L that are growing fastest in demand.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cell culture media bags market by geography and historical trend. The scope of the report extends to sizing of the cell culture media bags market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Thermo Fisher Scientific leads the cell culture media bags market with an extensive single-use portfolio that integrates media bags, connectors, and validated workflows under brands such as Gibco and Thermo Scientific, supporting applications from research through commercial biomanufacturing and benefiting from global manufacturing and distribution capabilities that ensure rapid supply to biopharma customers. Sartorius AG competes strongly through differentiated film chemistries and configurable bag designs optimized for gas permeability and sterility, leveraging its Bioprocess Solutions division and regional production sites to shorten lead times for large-volume (50–500 L and above) formats favored in clinical and pilot-scale production. Danaher (including Pall and Cytiva businesses) offers an expansive single-use platform that spans media preparation, sterile transfer, and filtration components, strengthened by strategic acquisitions that broaden its end-to-end bioprocessing reach and position it as a supplier for high-density, high-volume processes. Merck KGaA (MilliporeSigma in some regions) supplies media bags alongside a broad cell culture media and reagent portfolio under cGMP conditions, emphasizing batch-to-batch consistency, custom formulation services, and validated raw materials for cell and gene therapy workflows. Corning provides engineered single-use media bags and related disposables designed for integration with cell culture systems, emphasizing transparency, handling ergonomics, and compatibility with scaling processes from stem cell research to commercial production. Lonza Group supplies cell therapy–focused media bag solutions as part of its broader CDMO and contract development services, catering to the specialized needs of cell and gene therapy manufacturers and supporting large-scale clinical supply chains. Saint-Gobain Performance Plastics and Saint-Gobain subsidiaries produce advanced multilayer films and tubing used in media bag manufacture, focusing on polymer chemistries that improve oxygen/moisture barriers, reduce extractables, and extend shelf life for sensitive cultures. Parker Hannifin (SciLog) and Meissner Filtration Products offer complementary single-use fluid handling and sterile transfer systems plus reinforced bag designs and connector technologies that address rapid media transfer, aseptic sampling, and handling for high-volume operations. Fujifilm Irvine Scientific and Takara Bio provide application-focused media and bag combinations—pairing proprietary media formulations with compatible single-use containers and sampling ports to streamline validation and reduce compatibility risk for researchers and manufacturers moving to disposable workflows.
Across these ten companies, common competitive advantages include vertically integrated product lines, validated single-use systems, global manufacturing footprints, and materials science expertise that advances multilayer film technologies for improved gas exchange and reduced extractables—attributes critical as demand shifts toward larger bag formats and higher cell densities driven by monoclonal antibody production, vaccines, and cell and gene therapies. Strategic activity among leaders includes capacity expansions, targeted acquisitions to fill portfolio gaps (for example, filtration, connectors, or media), and product launches featuring integrated sampling, wider-bore ports, and reinforced handles to meet operational needs in GMP environments and decentralized modular biomanufacturing. Market reports indicate moderate consolidation with the top suppliers capturing a majority share of revenue, and projections show continuing growth driven by single-use adoption, rising biopharma production volumes, and increased R&D in regenerative medicine and cell therapies that demand sterile, scalable, and validated media bag solutions.
Innovation and regional manufacturing scale will likely determine near-term leadership as buyers prioritize supply security, regulatory support, and systems interoperability; manufacturers that combine advanced film chemistries, customizable configurations, and integrated service offerings (media formulation plus compatible bag systems) are best positioned to capture white-space opportunities in emerging markets and in high-volume formats above 500 L that are growing fastest in demand.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.